Remote Lifecycle Strategy Leader, Clinical Development

Ladders; United States; Remote; USD 280,000 - 350,000; Full time

Benefits offered by this job

Medical coverage

Life insurance

Stock incentives

Bonuses

PTO & holidays

Job summary

Ladders is seeking a Clinical Development Leader, Lifecycle Management to guide late-stage and marketed assets in a remote role. You will help shape development decisions, interpret emerging data, and represent the organization in cross-functional and external discussions.

You will influence early planning, including first-in-human studies and IND-enabling content for regulatory submissions, and provide pipeline-wide leadership across mechanisms and indications.

Qualifications

• Advanced scientific degree (MD, PharmD, PhD, or equivalent) required.
• Proven history of leading clinical trials and major development decisions.
• Experience owning regulatory submissions including IND, CTA, NDA, or MAA content and health authority interactions.
• Strong decision-making skills with the ability to interpret incomplete data.
• Demonstrated comfort in a dynamic work environment with evolving priorities.

Responsibilities

• Identify and drive lifecycle strategy for late-stage and marketed assets.
• Lead first-in-human and dose-escalation studies to inform next-stage development.
• Develop clinical strategy and content for IND-enabling submissions.
• Provide pipeline-wide leadership across different mechanisms and indications.
• Interpret emerging data to inform timely clinical decisions.
• Drive cross-functional teams and represent the organization credibly with external partners.

Education

MD/PhD/PharmD

Job description

Ladders is seeking a Clinical Development Leader, Lifecycle Management to guide late-stage and marketed assets in a remote role. You will help shape development decisions, interpret emerging data, and represent the organization in cross-functional and external discussions.

You will influence early planning, including first-in-human studies and IND-enabling content for regulatory submissions, and provide pipeline-wide leadership across mechanisms and indications.